The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
Open accessAbstract
Parkinson’s disease (PD) is a progressive neurodegenerative disease in the elderly, and no cure or disease-modifying therapies exist. Several lines of evidence suggest that mitochondrial dysfunction and oxidative stress have a central role in the dopaminergic neurodegeneration of PD. In this context, mitochondria-targeted therapies that improve mitochondrial function may have great promise in the prevention and treatment of PD. In this review, we discuss the recent developments in mitochondria-targeted antioxidants and their potential beneficial effects as a therapy for ameliorating mitochondrial dysfunction in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Superoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Reconciling the chemistry and biology of reactive oxygen species
Winterbourn, C. C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.85 · Cited by 2,504
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
Powers, S. K., & Jackson, M. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00031.2007 · Cited by 2,459
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789
Free radicals and antioxidants in human health: current status and future prospects.
Devasagayam, T. P. A., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S., & Lele, R. D. (2004) · PubMed · Cited by 1,575
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver
Okado-Matsumoto, A., & Fridovich, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105395200 · Cited by 1,013
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
Hamanaka, R. B., & Chandel, N. S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.002 · Cited by 1,011
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · cited 1×
“Postmortem studies have consistently shown high levels of oxidation of lipids, proteins, and nucleic acids in the SNc of sporadic PD brains [51-56].”
BackgroundZhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Signal transduction during oxidative stress
Vranova, E. (2002) · Journal of Experimental Botany · doi:10.1093/jexbot/53.372.1227 · Cited by 764
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Alcohol intake and risk of incident gout in men: a prospective study
Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W., & Curhan, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16000-5 · Cited by 748
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., & Dikalov, S. I. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 737
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 715
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
Mitochondrial α-Ketoglutarate Dehydrogenase Complex Generates Reactive Oxygen Species
Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E., Patel, M. S., & Beal, M. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1899-04.2004 · Cited by 688
Kirik, D., Rosenblad, C., & Björklund, A. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6848 · Cited by 663
Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr381 · Cited by 646
Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging
Marchi, S., Giorgi, C., Suski, J. M., Agnoletto, C., Bononi, A., Bonora, M., De Marchi, E., Missiroli, S., Patergnani, S., Poletti, F., et al. (2012) · Journal of Signal Transduction · doi:10.1155/2012/329635 · Cited by 640
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618
Hajnóczky, G., Csordás, G., Das, S., Garcia-Perez, C., Saotome, M., Sinha Roy, S., & Yi, M. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.08.016 · Cited by 613
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605 · cited 2×
“These mice exhibit reduced mtDNA expression, attenuated expression of respiratory chain function in dopaminergic neurons in nigra along with behavioral impairments and striatal dopamine depletion, mimicking progressive PD phenotypes starting from 18 weeks of age [89].”
BackgroundSchapira, A. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68970-8 · Cited by 591
Hydrogen peroxide: a Jekyll and Hyde signalling molecule
Gough, D. R., & Cotter, T. G. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.96 · Cited by 563
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Animal and human studies with the mitochondria‐targeted antioxidant MitoQ
Smith, R. A. J., & Murphy, M. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05627.x · Cited by 547
Mitochondria as a Pharmacological Target
Szewczyk, A., & Wojtczak, L. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.101 · Cited by 538
Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
Batinić-Haberle, I., Rebouças, J. S., & Spasojević, I. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2876 · Cited by 531
Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease
BEAL, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523
Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Da Ros, T., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0104-5 · Cited by 493
Mechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria
LIBERMAN, E. A., TOPALY, V. P., TSOFINA, L. M., JASAITIS, A. A., & SKULACHEV, V. P. (1969) · Nature · doi:10.1038/2221076a0 · Cited by 489
Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons
Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., Szeto, H. H., Park, B., & Reddy, P. H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100564 · Cited by 469
Selective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452
LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447
McManus, M. J., Murphy, M. P., & Franklin, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0552-11.2011 · Cited by 432
Targeting antioxidants to mitochondria: A new therapeutic direction
Sheu, S.-S., Nauduri, D., & Anders, M. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.10.007 · Cited by 414
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Environmental-induced oxidative stress in neurodegenerative disorders and aging
Migliore, L., & Coppedè, F. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.09.013 · Cited by 396
Plasma Urate and Risk of Parkinson's Disease
Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm127 · Cited by 390
Reactive oxygen species and mitochondrial diseases
Kirkinezos, I. G., & Moraes, C. T. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2001.0282 · Cited by 386
Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02250.x · Cited by 379 · cited 2×
“, and it has undergone Phase I and II clinical trials [157, 158].”
BackgroundCreatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A. J., Cochemé, H. M., Murphy, M. P., & Dominiczak, A. F. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130351 · Cited by 367
Iron-Sulfur Protein Biogenesis in Eukaryotes: Components and Mechanisms
Lill, R., & Mühlenhoff, U. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104538 · Cited by 365
Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358
Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Liu, B., & Hong, J.-S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 337
Antonenko, Y. N., Avetisyan, A. V., Bakeeva, L. E., Chernyak, B. V., Chertkov, V. A., Domnina, L. V., Ivanova, O. Y., Izyumov, D. S., Khailova, L. S., Klishin, S. S., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120018 · Cited by 326
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
Gu, M., Cooper, J. M., Taanman, J. W., & Schapira, A. H. V. (1998) · Annals of Neurology · doi:10.1002/ana.410440207 · Cited by 313
Levodopa for the Treatment of Parkinson's Disease
LeWitt, P. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0800326 · Cited by 312
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
Schwarzschild, M. A. (2008) · Archives of Neurology · doi:10.1001/archneur.2008.65.6.nct70003 · Cited by 310
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308
Murphy, M. P., Echtay, K. S., Blaikie, F. H., Asin-Cayuela, J., Cochemé, H. M., Green, K., Buckingham, J. A., Taylor, E. R., Hurrell, F., Hughes, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308529200 · Cited by 303
Redox imbalance in Parkinson's disease
Chinta, S. J., & Andersen, J. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.02.005 · Cited by 302
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Oxidative and nitrosative stress in Parkinson's disease
Tsang, A. H. K., & Chung, K. K. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.006 · Cited by 300
Superoxide and hydrogen peroxide production by Drosophila mitochondria
Miwa, S., St-Pierre, J., Partridge, L., & Brand, M. D. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00464-7 · Cited by 299
Oxidative Stress: Apoptosis in Neuronal Injury
Poh Loh, K., Hong Huang, S., De Silva, R., H. Tan, B., & Zhun Zhu, Y. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249515 · Cited by 297
Signal transduction during oxidative stress.
Vranová, E., Inzé, D., & Breusegem, F. V. (2002) · PubMed · Cited by 296
Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E., & Masliah, E. (2004) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 295
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279
Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
Protein oxidation and cellular homeostasis: Emphasis on metabolism
Cecarini, V., Gee, J., Fioretti, E., Amici, M., Angeletti, M., Eleuteri, A. M., & Keller, J. N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.039 · Cited by 274
Hartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270
A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria
Trnka, J., Blaikie, F. H., Smith, R. A. J., & Murphy, M. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.036 · Cited by 265
Lowes, D. A., Thottakam, B. M. V., Webster, N. R., Murphy, M. P., & Galley, H. F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.003 · Cited by 261
Beal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256
Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.022 · Cited by 251
Dhanasekaran, A., Kotamraju, S., Kalivendi, S. V., Matsunaga, T., Shang, T., Keszler, A., Joseph, J., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404003200 · Cited by 241
Self-citationIntakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
Zhang, S. M., Hernán, M. A., Chen, H., Spiegelman, D., Willett, W. C., & Ascherio, A. (2002) · Neurology · doi:10.1212/01.wnl.0000028688.75881.12 · Cited by 240
Perier, C., Bové, J., Wu, D.-C., Dehay, B., Choi, D.-K., Jackson-Lewis, V., Rathke-Hartlieb, S., Bouillet, P., Strasser, A., Schulz, J. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609874104 · Cited by 229
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220 · cited 1×
“Additionally, impairment of complex-I activity has been reported in the substantia nigra, platelets and skeletal muscles of PD patients [85, 86].”
BackgroundA randomized clinical trial of coenzyme Q 10 and GPI-1485 in early Parkinson disease
The NINDS NET-PD Investigators (2007) · Neurology · doi:10.1212/01.wnl.0000250355.28474.8e · Cited by 219
Rodriguez-Cuenca, S., Cochemé, H. M., Logan, A., Abakumova, I., Prime, T. A., Rose, C., Vidal-Puig, A., Smith, A. C., Rubinsztein, D. C., Fearnley, I. M., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.039 · Cited by 218
Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease
Davis, J. W., Grandinetti, A., Waslien, C. J., Ross, G. W., White, L. R., & Morens, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008954 · Cited by 216
Neuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders
Mattson, M. P. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1997 · Cited by 214
Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson???s Disease
Jankovic, J., & Stacy, M. (2007) · CNS Drugs · doi:10.2165/00023210-200721080-00005 · Cited by 213
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease
Fahn, S. (1992) · Annals of Neurology · doi:10.1002/ana.410320722 · Cited by 211
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
Bender, A., Koch, W., Elstner, M., Schombacher, Y., Bender, J., Moeschl, M., Gekeler, F., Müller-Myhsok, B., Gasser, T., Tatsch, K., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000238518.34389.12 · Cited by 204
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199
Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
Ghosh, A., Chandran, K., Kalivendi, S. V., Joseph, J., Antholine, W. E., Hillard, C. J., Kanthasamy, A., Kanthasamy, A., & Kalyanaraman, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.028 · Cited by 190
Self-citationMercer, J. R., Yu, E., Figg, N., Cheng, K.-K., Prime, T. A., Griffin, J. L., Masoodi, M., Vidal-Puig, A., Murphy, M. P., & Bennett, M. R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.026 · Cited by 188
Kitazawa, M., Anantharam, V., & Kanthasamy, A. G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00726-2 · Cited by 186
Self-citationSomayajulu, M., McCarthy, S., Hung, M., Sikorska, M., Borowy-Borowski, H., & Pandey, S. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.021 · Cited by 181
Mandemakers, W., Morais, V. A., & De Strooper, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.03443 · Cited by 176
A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results
(2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181342f32 · Cited by 174
Moon, Y., Lee, K. H., Park, J., Geum, D., & Kim, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03112.x · Cited by 174
Mitochondria-targeted antioxidants as therapies.
Smith, R. A. J., & Murphy, M. P. (2011) · PubMed · Cited by 173
Bakeeva, L. E., Barskov, I. V., Egorov, M. V., Isaev, N. K., Kapelko, V. I., Kazachenko, A. V., Kirpatovsky, V. I., Kozlovsky, S. V., Lakomkin, V. L., Levina, S. B., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s000629790812002x · Cited by 173
Mitochondrial Redox Cycling of Mitoquinone Leads to Superoxide Production and Cellular Apoptosis
Doughan, A. K., & Dikalov, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1693 · Cited by 172
Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells
VEJRAZKA, M., MICEK, R., & STIPEK, S. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.12.008 · Cited by 172
The Scientific Basis for the Current Treatment of Parkinson's Disease
Olanow, C. W. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104422 · Cited by 170
Yang, L., Zhao, K., Calingasan, N. Y., Luo, G., Szeto, H. H., & Beal, M. F. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2445 · Cited by 169
Proteome analysis of human substantia nigra in Parkinson's disease
Werner, C. J., Heyny-von Haussen, R., Mall, G., & Wolf, S. (2008) · Proteome Science · doi:10.1186/1477-5956-6-8 · Cited by 167
Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
Shoulson, & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430309 · Cited by 165
Non-motor extranigral signs and symptoms in Parkinson's disease
Wolters, E. C. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70770-9 · Cited by 163
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
Chen, H., Mosley, T. H., Alonso, A., & Huang, X. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp033 · Cited by 161
Peng, J., Stevenson, F. F., Doctrow, S. R., & Andersen, J. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500984200 · Cited by 160
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
Lan, J., & Jiang, D. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 159
V. Skulachev, M., N. Antonenko, Y., N. Anisimov, V., V. Chernyak, B., A. Cherepanov, D., A. Chistyakov, V., V. Egorov, M., G. Kolosova, N., A. Korshunova, G., G. Lyamzaev, K., et al. (2011) · Current Drug Targets · doi:10.2174/138945011795528859 · Cited by 156
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann, A., Michel, P. P., Troadec, J., Prigent, A., Faucheux, B. A., Ruberg, M., Agid, Y., & Hirsch, É. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00160.x · Cited by 156
The Promise of Neuroprotective Agents in Parkinson?s Disease
Seidl, S. E., & Potashkin, J. A. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00068 · Cited by 156
Xun, Z., Rivera, S., Ayala‐Peña, S., Lim, J. I., Budworth, H., Skoda, E. M., Robbins, P. D., Niedernhofer, L. J., Wipf, P., & McMurray, C. T. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.001 · Cited by 155
MitoQ administration prevents endotoxin-induced cardiac dysfunction
Supinski, G. S., Murphy, M. P., & Callahan, L. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90902.2008 · Cited by 154
Solesio, M. E., Prime, T. A., Logan, A., Murphy, M. P., Jiménez, M. D. M. A., Jordán, J., & Galindo, M. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.009 · Cited by 153
Hughes, G., Murphy, M. P., & Ledgerwood, E. C. (2005) · Biochemical Journal · doi:10.1042/bj20050078 · Cited by 153
Cantu, D., Schaack, J. B., & Patel, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007095 · Cited by 151
Transcellular Transport of a Highly Polar 3+ Net Charge Opioid Tetrapeptide
Zhao, K., Luo, G., Zhao, G., Schiller, P. W., & Szeto, H. H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040147 · Cited by 150
SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS
Milani, P., Gagliardi, S., Cova, E., & Cereda, C. (2011) · Neurology Research International · doi:10.1155/2011/458427 · Cited by 149
Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis
Galley, H. F. (2010) · Critical Care · doi:10.1186/cc9098 · Cited by 148
Liang, H., Sedlić, F., Bosnjak, Z. J., & Nilakantan, V. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.018 · Cited by 146
Neroev, V. V., Archipova, M. M., Bakeeva, L. E., Фурсова, А. Ж., Григорян, Э. Н., Grishanova, A. Y., Иомдина, Е. Н., Ivashchenko, Z. N., Катаргина, Л. А., Хорошилова-Маслова, И. П., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120043 · Cited by 140
Mitochondrial function is differentially affected upon oxidative stress
Cardoso, S. M., Pereira, C., & Oliveira, C. R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00205-6 · Cited by 137
Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.
Tanner, C. M. (2003) · PubMed · Cited by 131
Synthesis and Characterization of a Triphenylphosphonium-conjugated Peroxidase Mimetic
Filipovska, A., Kelso, G. F., Brown, S. E., Beer, S. M., Smith, R. A. J., & Murphy, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501148200 · Cited by 130
Thomas, M. P., Chartrand, K., Reynolds, A. D., Vitvitsky, V., Banerjee, R. V., & Gendelman, H. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04315.x · Cited by 127
Parkin and Parkinsonʼs disease
Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 126
Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced Apoptosis
Kanthasamy, A. G., Kitazawa, M., Kanthasamy, A., & Anantharam, V. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310275 · Cited by 124
Self-citationGhosh, A., Kanthasamy, A., Joseph, J., Anantharam, V., Srivastava, P., Dranka, B. P., Kalyanaraman, B., & Kanthasamy, A. G. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-241 · Cited by 124
Self-citationReactive Oxygen and Targeted Antioxidant Administration in Endothelial Cell Mitochondria
O'Malley, Y., Fink, B. D., Ross, N. C., Prisinzano, T. E., & Sivitz, W. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608268200 · Cited by 123
Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis
Chacko, B. K., Srivastava, A., Johnson, M. S., Benavides, G. A., Chang, M. J., Ye, Y., Jhala, N., Murphy, M. P., Kalyanaraman, B., & Darley-Usmar, V. M. (2011) · Hepatology · doi:10.1002/hep.24377 · Cited by 122
Self-citationSomatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
Simon, D. K., Lin, M. T., Zheng, L., Liu, G.-J., Ahn, C. H., Kim, L. M., Mauck, W. M., Twu, F., Beal, M. F., & Johns, D. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00037-x · Cited by 118
Roghani, M., & Behzadi, G. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03296-0 · Cited by 118
Horváth, T. L., Diano, S., Léránth, C., García‐Segura, L. M., Cowley, M. A., Shanabrough, M., Elsworth, J. D., Sótonyi, P., Roth, R. H., Dietrich, E. H., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0163 · Cited by 117
Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid
Forman, H. J., & Kennedy, J. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41421-x · Cited by 115
Anantharam, V., Kaul, S., Song, C., Kanthasamy, A., & Kanthasamy, A. G. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.08.008 · Cited by 115
Self-citationLim, S., Rashid, M., Jang, M.-R., Kim, Y., Won, H., Lee, J., Woo, J., Kim, Y. S., Murphy, M., Ali, L., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335802 · Cited by 113
Anisimov, V. N., Bakeeva, L. E., Egormin, P. A., Филенко, О. Ф., Исакова, Е. Ф., Манских, В. Н., Mikhelson, V. M., Panteleeva, A. A., PASYUKOVA, E. G., Pilipenko, D. I., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120055 · Cited by 113
Voleti, V. B., & Hubschman, J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.01.018 · Cited by 112
Kizhakekuttu, T. J., Wang, J., Dharmashankar, K., Ying, R., Gutterman, D. D., Vita, J. A., & Widlansky, M. E. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.256024 · Cited by 106
Zang, Q. S., Sadek, H. A., Maass, D. L., Martinez, B., Ma, L., Kilgore, J. A., Williams, N. S., Frantz, D. E., Wigginton, J. G., Nwariaku, F. E., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00203.2011 · Cited by 104
Mitochondrial Dysfunction in Idiopathic Parkinson Disease
Parker, W. D., & Swerdlow, R. H. (1998) · The American Journal of Human Genetics · doi:10.1086/301812 · Cited by 99
Mitochondria, oxidative stress, and antioxidant defences.
Lenaz, G., Bovina, C., Formiggini, G., & Castelli, G. P. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4179 · Cited by 99
Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
Scheider, W. L., Hershey, L. A., Vena, J. E., Holmlund, T., Marshall, J. R., & Freudenheim, J. L. (1997) · Movement Disorders · doi:10.1002/mds.870120209 · Cited by 98
Guerreiro, S., Ponceau, A., Toulorge, D., Martin, E., Alvarez‐Fischer, D., Hirsch, É. C., & Michel, P. P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06040.x · Cited by 96
Agapova, L. S., Chernyak, B. V., Domnina, L. V., Dugina, V. B., Efimenko, A. Y., Fetisova, E. K., Ivanova, O. Y., Kalinina, N., Хромова, Н. В., Kopnin, B. P., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120031 · Cited by 93
Liang, L., Huang, J., Fulton, R. E., Day, B. J., & Patel, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0019-07.2007 · Cited by 93
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease
Haas, R. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.008 · Cited by 92
Chou, K. L., Taylor, J. L., & Patil, P. G. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.06.010 · Cited by 92
Neužil, J., Widén, C., Gellert, N., Swettenham, E., Zobalová, R., Dong, L., Wang, X., Lidebjer, C., Dalen, H., Headrick, J. P., et al. (2007) · Redox Report · doi:10.1179/135100007x200227 · Cited by 90
Gualano, B., de Salles Painelli, V., Roschel, H., Lugaresi, R., Dorea, E., Artioli, G. G., Lima, F. R., da Silva, M. E. R., Cunha, M. R., Seguro, A. C., et al. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1676-3 · Cited by 88
Andres, R. H., Huber, A. W., Schlattner, U., Pérez-Bouza, A., Krebs, S. H., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.004 · Cited by 86
Antioxidants, Supplements, and Parkinson's Disease
Weber, C. A., & Ernst, M. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g551 · Cited by 86
Kitazawa, M., Wagner, J. R., Kirby, M. L., Anantharam, V., & Kanthasamy, A. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.26 · Cited by 84
Self-citationPurified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles
Nehilla, B. J., BERGKVIST, M., Popat, K. C., & Desai, T. A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.001 · Cited by 73
Preformed β-amyloid fibrils are destabilized by coenzyme Q10 in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.132 · Cited by 66
Pung, Y. F., Ročić, P., Murphy, M. P., Smith, R. A. J., Hafemeister, J. L., Ohanyan, V. A., Guarini, G., Yin, L., & Chilian, W. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241802 · Cited by 65
A Mitochondria-Targeted Macrocyclic Mn(II) Superoxide Dismutase Mimetic
Kelso, G. F., Maroz, A., Cochemé, H. M., Logan, A., Prime, T. A., Peskin, A. V., Winterbourn, C. C., James, A. M., Ross, M. F., Brooker, S., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.005 · Cited by 62
MPTP toxicity in the mouse brain and vitamin E
Odunze, I. N., Klaidman, L. K., & Adams, J. D., Jr. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90665-v · Cited by 59
Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
Abdel‐Salam, O. M. E. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786441867 · Cited by 50
Mao, G., Kraus, G. A., Kim, I., Spurlock, M. E., Bailey, T. B., Zhang, Q., & Beitz, D. C. (2010) · The Journal of Nutrition · doi:10.3945/jn.110.121715 · Cited by 48
Dranka, B. P., Gifford, A., Ghosh, A., Zielonka, J., Joseph, J., Kanthasamy, A. G., & Kalyanaraman, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.034 · Cited by 43
Self-citationKanegae, M. P. P., Condino‐Neto, A., Pedroza, L. A., de Almeida, A. C., Rehder, J., da Fonseca, L. M., & Ximenes, V. F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.073 · Cited by 39
Covey, M. V., Murphy, M. P., Hobbs, C., Smith, R. A. J., & Oorschot, D. E. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.026 · Cited by 36
Reddy, T. P., Mańczak, M., Calkins, M. J., Mao, P., Reddy, A. P., Shirendeb, U. P., Park, B. S., & Reddy, P. H. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8010203 · Cited by 36
PCR Analysis of platelet mtDNA: Lack of specific changes in Parkinson's disease
Sandy, M. S., Langston, J. W., Smith, M. T., & Monte, D. A. D. (1993) · Movement Disorders · doi:10.1002/mds.870080114 · Cited by 32
Testing a Novel Strategy Against Parkinson's Disease
Couzin, J. (2007) · Science · doi:10.1126/science.315.5820.1778 · Cited by 31
Knaryan, V. H., Samantaray, S., Gal, C. L., Ray, S. K., & Banik, N. L. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07320.x · Cited by 24
Cytochrome c as an amplifier of ROS release in mitochondria
Ov, A., Kolchinskaya, L. I., Nosar, V. I., Bouryi, V. A., Im, M., & Сагач, В. Ф. (2012) · Fìzìologìčnij žurnal · doi:10.15407/fz58.01.003 · Cited by 23
NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease
Bloom, M. Z. (2007) · PsycEXTRA Dataset · doi:10.1037/e607462007-001 · Cited by 12
Parkinson Disease: Extranigral, Multisystem, and α-Synuclein “Plus”
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.140 · Cited by 8
Cited by
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Vascular oxidative stress, nitric oxide and atherosclerosis
Li, H., Horke, S., & Förstermann, U. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.001 · Cited by 656
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
A Mitochondrial Switch Promotes Tumor Metastasis
Porporato, P. E., Payen, V. L., Pérez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.043 · Cited by 571
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Metadata
- Authors
- Jin, H., Kanthasamy, A., Ghosh, A., Anantharam, V., Kalyanaraman, B., & Kanthasamy, A. G.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 1842
- Issue
- 8
- Pages
- 1282-1294
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2058912318
- Cited by
- 361
- References
- 191
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.